MCV ST activates specific gene transcription by redirecting the activity of the Tip60/p400 complex.
MCV ST 通过重定向 Tip60/p400 复合物的活性来激活特定基因转录。
基本信息
- 批准号:9753448
- 负责人:
- 金额:$ 3.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcetyltransferaseAddressAntigen TargetingBindingBinding SitesCellsChIP-seqChromatinComplexDNA Tumor VirusesDataDepositionDevelopmentDiseaseEpigenetic ProcessGene ActivationGene ExpressionGene Expression RegulationGenesGenetic TranscriptionHistonesHumanIn VitroIncidenceLarge T AntigenLysineMalignant Epithelial CellMeasuresMediatingMerkel CellsMerkel cell carcinomaMethodsNucleosomesOncogenicPolyomavirusPolyomavirus Transforming AntigensProteinsReportingRoleSiteSkin CancerSmall T AntigenSystemTP53 geneTranscription CoactivatorTransgenic MiceTumor AntigensVariantViral ProteinsVirusWorkantigen bindingcell transformationcombathistone acetyltransferaseimprovedinsightmelanomametaplastic cell transformationmortalitymouse modelmutantprogramspromoterrecruittargeted treatmenttranscriptome sequencingtumor
项目摘要
Project Abstract:
Merkel cell polyomavirus (MCV) is a small DNA tumor virus that causes approximately 80% of Merkel cell
carcinoma (MCC), a highly aggressive skin cancer. Since the discovery of MCV in 2008, it has been shown
that the MCV tumor antigens small T antigen (ST) and large T antigen (LT) are the only viral proteins
consistently expressed in virus-positive MCC cells. Expression of ST alone in Rat1 cells was sufficient to
induce cellular transformation suggesting that ST is the primary driver of cellular transformation in MCC
development. Our lab determined that ST forms a specific complex with L-Myc/MAX and the Tip60/p400
complex (SLT complex) and that a ST mutant incapable of binding to L-Myc and the Tip60/p400 complex
cannot transform cells. The Tip60/p400 complex is a large multi-subunit complex that has lysine
acetyltransferase activity (Tip60 protein) and nucleosome exchange activity (p400 protein). Both of these
activities have been correlated with active gene transcription but further work is necessary to fully understand
the relationship between Tip60/p400 complex activity and gene expression. We hypothesize that MCV ST
redirects the Tip60/p400 complex to L-Myc binding sites to activate a transcriptional program requiring
their lysine acetyltransferase and histone remodeling activity to drive cellular transformation. In Aim 1,
we will assess the effect of ST on Tip60/p400 complex binding and we will compare the direct targets of the
Tip60/p400 complex in control cells with cells expressing ST to determine if ST redirects the complex from
“normal” Tip60/p400 complex binding sites to SLT target gene promoters to activate SLT target gene
transcription. By comparing the list of genes that are direct targets of the SLT complex in normal human cells
to those we previously identified in virus-positive MCC cells, we will generate a list of genes that are
consistently regulated by ST. In Aim 2, we will assess the contribution of Tip60 histone acetyltransferase (HAT)
and p400 nucleosome remodeling activities to ST-mediated gene expression changes and cellular
transformation. In Aim 3, we will adapt the Fkbp/Frb inducible recruitment for epigenetic editing by Cas9 (FIRE-
Cas9) method to the Tip60/p400 complex and then use this system to recruit the Tip60/p400 complex to SLT
target genes in the absence of ST. Upon recruitment, we will measure changes to ST target gene transcription
and the level of Tip60/p400-specific histone marks at SLT target gene promoters. Insights gained from
investigating the ST interaction with L-Myc and the Tip60/p400 complex will provide a deeper
understanding of the oncogenic roles of these factors and understanding the activities of the SLT
complex will lead to identification of improved targeted therapies to combat MCC.
项目摘要:
Merkel细胞多病毒(MCV)是一种小的DNA肿瘤病毒,可引起约80%的默克尔细胞
癌(MCC),一种高度侵略性的皮肤癌。自2008年发现MCV以来,已显示
MCV肿瘤抗原小T抗原(ST)和大T抗原(LT)是唯一的病毒蛋白
在病毒阳性MCC细胞中始终表达。单独的ST在Rat1细胞中的表达足以
诱导细胞转化,表明ST是MCC中细胞转化的主要驱动力
发展。我们的实验室确定ST与L-MYC/MAX和TIP60/P400形成特定的复合物
复合物(SLT复合物)和ST突变体与L-MYC和TIP60/P400复合物的结合能力
无法转化细胞。 TIP60/P400综合体是一个具有歌词的大型多工厂综合体
乙酰转移酶活性(TIP60蛋白)和核小体交换活性(P400蛋白)。这两个
活动与主动基因转录有关,但需要进一步的工作才能充分理解
TIP60/P400复合活性与基因表达之间的关系。我们假设MCV ST
将TIP60/P400复合物重定向到L-MYC结合位点,以激活需要转录程序
他们的赖氨酸乙酰转移酶和Hisstone重塑活性以驱动细胞转化。在AIM 1中,
我们将评估ST对TIP60/P400复合物结合的影响,并将比较
对照细胞中的TIP60/P400复合物与表达ST的细胞以确定ST是否从
与SLT靶基因启动子激活SLT靶基因的“正常” TIP60/P400复合结合位点
转录。通过比较正常人细胞中SLT复合物的直接靶标的基因列表
对于我们先前在病毒阳性MCC细胞中发现的人,我们将生成一个基因列表
始终受st的调节。在AIM 2中,我们将评估TIP60组蛋白乙酰转移酶(HAT)的贡献
和P400核小体重塑活性至ST介导的基因表达变化和细胞
转型。在AIM 3中,我们将适应FKBP/FRB诱导招聘的表观遗传编辑(Fire--
CAS9)tip60/p400复合物的方法,然后使用此系统募集TIP60/P400复合物到SLT
靶基因在没有st的情况下。招募后,我们将测量对ST靶基因转录的变化
以及SLT靶基因启动子的TIP60/P400特异性Hisstone标记的水平。从中获得的见解
研究与L-MYC和TIP60/P400复合物的ST相互作用将提供更深的
了解这些因素的致癌作用并了解SLT的活动
复合物将导致对靶向疗法的改进来对抗MCC。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Camille Cushman其他文献
Camille Cushman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Camille Cushman', 18)}}的其他基金
MCV ST activates specific gene transcription by redirecting the activity of the Tip60/p400 complex.
MCV ST 通过重定向 Tip60/p400 复合物的活性来激活特定基因转录。
- 批准号:
9896661 - 财政年份:2019
- 资助金额:
$ 3.82万 - 项目类别:
相似国自然基金
N-乙酰转移酶NAT10调控胰岛β细胞功能的作用和机制研究
- 批准号:82370825
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
乙酰转移酶ESCO1促进耐药分子mRNA出核诱导三阴乳腺癌紫杉醇耐药的机制研究
- 批准号:82373369
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
3’tRNA衍生片段tRF-Val靶向EEF1A1招募乙酰转移酶KAT5和HSP90AB1复合物促进胃癌进展的机制
- 批准号:82302959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
组蛋白乙酰转移酶P300招募TET1共同调控ZNF334基因表达在结直肠癌生长中的机制研究
- 批准号:82302970
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
SCML4协同乙酰化转移酶HBO1促进Trm表观遗传修饰增强抗肿瘤免疫的分子机制研究
- 批准号:82303153
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 3.82万 - 项目类别:
Scalable platforms for understudied histone modifications and modifiers
用于未充分研究的组蛋白修饰和修饰剂的可扩展平台
- 批准号:
10567849 - 财政年份:2023
- 资助金额:
$ 3.82万 - 项目类别:
Epigenetic mechanisms of histone methyltransferase ASH1L in autism spectrum disorder
组蛋白甲基转移酶 ASH1L 在自闭症谱系障碍中的表观遗传机制
- 批准号:
10743048 - 财政年份:2023
- 资助金额:
$ 3.82万 - 项目类别:
Investigating essential chromatin regulators in cancers with SWI/SNF mutations
研究具有 SWI/SNF 突变的癌症中的必需染色质调节因子
- 批准号:
10607451 - 财政年份:2023
- 资助金额:
$ 3.82万 - 项目类别:
Development of First-in-Class PDE5/HAT Directed LigandsModulating Molecular Pathways involved in Synaptic Plasticity
开发一流的 PDE5/HAT 定向配体调节参与突触可塑性的分子途径
- 批准号:
10654103 - 财政年份:2023
- 资助金额:
$ 3.82万 - 项目类别: